4038 related articles for article (PubMed ID: 7000360)
1. Cell kinetic alterations in normal and neoplastic cell populations in vitro and in vivo following vincristine: a reply to Dr Camplejohn's review article.
Klein HO
Cell Tissue Kinet; 1980 Jul; 13(4):425-34. PubMed ID: 7000360
[TBL] [Abstract][Full Text] [Related]
2. A critical review of the use of vincristine (VCR) as a tumour cell synchronizing agent in cancer therapy.
Camplejohn RS
Cell Tissue Kinet; 1980 May; 13(3):327-35. PubMed ID: 6989508
[TBL] [Abstract][Full Text] [Related]
3. An in vivo double labelling study of the subsequent fate of cells arrested in metaphase by vincristine in the JB-1 mouse ascites tumour.
Camplejohn RS; Schultze B; Maurer W
Cell Tissue Kinet; 1980 May; 13(3):239-50. PubMed ID: 7371063
[TBL] [Abstract][Full Text] [Related]
4. Studies on the so-called "synchronization therapy" of tumors with vincristine.
Schultze B; Jellinghaus W; Basler U; Dettmer J; Maurer W
J Cancer Res Clin Oncol; 1983; 105(3):266-74. PubMed ID: 6853589
[TBL] [Abstract][Full Text] [Related]
5. Comparative investigations on the effect of the phase-specific drug vincristine (VCR) on the proliferation kinetics of a solid experimental tumor.
Féaux de Lacroix W; Klein M
J Cancer Res Clin Oncol; 1983; 106(3):187-91. PubMed ID: 6654953
[TBL] [Abstract][Full Text] [Related]
6. Effects of vincristine on cell survival, cell cycle progression, and mitotic accumulation in asynchronously growing Sarcoma 180 cells.
Mujagic H; Chen SS; Geist R; Occhipinti SJ; Conger BM; Smith CA; Schuette WH; Shackney SE
Cancer Res; 1983 Aug; 43(8):3591-7. PubMed ID: 6861131
[TBL] [Abstract][Full Text] [Related]
7. [Is in-vivo synchronization of cells possible with vincristine?].
Schultze B
Strahlentherapie Sonderb; 1978; 75():46-51. PubMed ID: 555054
[No Abstract] [Full Text] [Related]
8. Comparative investigations on the effect of different dose schedules of the phase-specific drug vincristine (VCR) on the proliferation kinetics of a solid experimental tumour.
Féaux de Lacroix W; Mallmann H
Cell Tissue Kinet; 1984 Nov; 17(6):583-91. PubMed ID: 6488276
[TBL] [Abstract][Full Text] [Related]
9. Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.
Hill BT; Whelan RD
J Natl Cancer Inst; 1981 Aug; 67(2):437-43. PubMed ID: 6943380
[TBL] [Abstract][Full Text] [Related]
10. Investigations on partial synchronization in ascites tumors of different ploidy and in solid transplantable tumors.
Lennartz KJ; Klein HO; Feaux de Lacroix W
Recent Results Cancer Res; 1975; (52):179-86. PubMed ID: 1234998
[No Abstract] [Full Text] [Related]
11. The effect of vincristine on mouse jejunal crypt cells of differing cell age: double labelling autoradiographic studies using 3H- and 14C-TdR.
Jellinghaus W; Schultze B; Maurer W
Cell Tissue Kinet; 1977 Mar; 10(2):147-56. PubMed ID: 856474
[TBL] [Abstract][Full Text] [Related]
12. Vincristine sulfate-induced cell transformation, mitotic inhibition and aneuploidy in cultured Syrian hamster embryo cells.
Tsutsui T; Suzuki N; Maizumi H; Barrett JC
Carcinogenesis; 1986 Jan; 7(1):131-5. PubMed ID: 3943135
[TBL] [Abstract][Full Text] [Related]
13. Reproductive potential of vincristine-treated multinucleate carcinoma cells.
Tennyson GS; Burbach BJ; Lane BP
Cancer Treat Rep; 1983 Dec; 67(12):1113-4. PubMed ID: 6652628
[TBL] [Abstract][Full Text] [Related]
14. Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenografts.
Horton JK; Houghton PJ; Houghton JA
Biochem Pharmacol; 1988 Oct; 37(20):3995-4000. PubMed ID: 3190743
[TBL] [Abstract][Full Text] [Related]
15. Accumulation and release of vinblastine and vincristine by HeLa cells: light microscopic, cinematographic, and biochemical study.
Lengsfeld AM; Dietrich J; Schultze-Maurer B
Cancer Res; 1982 Sep; 42(9):3798-805. PubMed ID: 7105045
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of the new mitotic inhibitor 5-chloropyrimidin-2-one and of vincristine on human cells in vitro.
Wibe E; Oftebro R; Christensen T; Laland SG; Pettersen EO; Lindmo T
Cancer Res; 1978 Mar; 38(3):560-5. PubMed ID: 626961
[No Abstract] [Full Text] [Related]
17. Age-dependent cell inactivation by vincristine alone or in combination with 1-propargyl-5-chloropyrimidin-2-one.
Wibe E
Cancer Res; 1980 Jun; 40(6):2069-73. PubMed ID: 7371040
[TBL] [Abstract][Full Text] [Related]
18. Experimental investigations on a sequential combination chemotherapy protocol.
Klein HO; Toermer HJ; Christian E; Coerper C; Lennartz KJ; Akokan G
J Cancer Res Clin Oncol; 1980 Jan; 96(1):65-78. PubMed ID: 7358773
[TBL] [Abstract][Full Text] [Related]
19. A reappraisal of the stathmokinetic technique. I. An experimental study of a murine plasmacytoma with special reference to metaphase degeneration.
Challoner D
Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 42(1):95-110. PubMed ID: 6132492
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
